0000950123-19-005099.txt : 20190515
0000950123-19-005099.hdr.sgml : 20190515
20190515090133
ACCESSION NUMBER: 0000950123-19-005099
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190331
FILED AS OF DATE: 20190515
DATE AS OF CHANGE: 20190515
EFFECTIVENESS DATE: 20190515
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bain Capital Life Sciences Investors, LLC
CENTRAL INDEX KEY: 0001703031
IRS NUMBER: 813996001
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18477
FILM NUMBER: 19825308
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6175162878
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001703031
XXXXXXXX
03-31-2019
03-31-2019
Bain Capital Life Sciences Investors, LLC
200 Clarendon Street
Boston
MA
02116
13F HOLDINGS REPORT
028-18477
Y
Bain Capital Life Sciences Investors, LLC is the general partner of Bain Capital Life Sciences Partners, LP, which is the general partner of Bain Capital Life Sciences Fund, L.P.
Adam Koppel
Managing Dir. of Bain Capital Life Sciences Investors, LLC
617-516-2000
/s/ Adam Koppel
Boston
MA
05-15-2019
2
6
250119
false
1
28-18476
Bain Capital Life Scinces Partners, LP
2
28-18478
Bain Capital Life Scinces Fund, LP
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
DICERNA PHARMACEUTICALS INC
COM
253031108
130828
8930237
SH
SOLE
8930237
0
0
MARINUS PHARMACEUTICALS INC
COM
56854Q101
21079
5042735
SH
SOLE
5042735
0
0
INFLARX NV
COM
N44821101
27688
732670
SH
SOLE
732670
0
0
SOLID BIOSCIENCES INC
COM
83422E105
18303
1989444
SH
SOLE
1989444
0
0
APTINYX INC
COM
03836N103
9012
2225092
SH
SOLE
2225092
0
0
REPLIMUNE GROUP INC
COM
76029N106
43209
2838968
SH
SOLE
2838968
0
0